Image-Guided Drug Nanosystems in Lung Cancer therapy

"Image-Guided Drug Nanosystems in Lung Cancer therapy" is a comprehensive and groundbreaking book that explores the convergence of nanotechnology, imaging techniques, and precision medicine in the battle against lung cancer. This book provides a deep and insightful overview of the global burden of lung cancer and the pressing need for more targeted and precise therapies. It delves into the pivotal role of Nano system-based drug delivery in enhancing the efficacy and safety of cancer treatments, with a specific focus on lung cancer. The integration of various imaging modalities, including positron emission tomography (PET), magnetic resonance imaging (MRI), and fluorescence imaging, is thoroughly examined to guide the precise delivery of therapeutics to lung tumors.The book discusses the design considerations for advanced nanosystems, emphasizing particle size, surface modification, and controlled drug release mechanisms, as well as targeting strategies like passive targeting through the enhanced permeability and retention (EPR) effect and active targeting using ligand-functionalized nanosystems and with new technologies based nanosystems for Lung cancer treatment.

Autorentext

Professor Dr. Ritesh Fule is a renowned formulation researcher who has made significant contributions to the field of pharmaceuticals and drug delivery systems. With a distinguished academic and research career, Professor Fule has been at the forefront of developing innovative formulations for drug delivery, particularly in the context of cancer.

Klappentext

"Image-Guided Drug Nanosystems in Lung Cancer therapy" is a comprehensive and groundbreaking book that explores the convergence of nanotechnology, imaging techniques, and precision medicine in the battle against lung cancer. This book provides a deep and insightful overview of the global burden of lung cancer and the pressing need for more targeted and precise therapies. It delves into the pivotal role of Nano system-based drug delivery in enhancing the efficacy and safety of cancer treatments, with a specific focus on lung cancer. The integration of various imaging modalities, including positron emission tomography (PET), magnetic resonance imaging (MRI), and fluorescence imaging, is thoroughly examined to guide the precise delivery of therapeutics to lung tumors.The book discusses the design considerations for advanced nanosystems, emphasizing particle size, surface modification, and controlled drug release mechanisms, as well as targeting strategies like passive targeting through the enhanced permeability and retention (EPR) effect and active targeting using ligand-functionalized nanosystems and with new technologies based nanosystems for Lung cancer treatment.